ONO-4578 + ONO-4538
Phase 1Active 0 views this week 0 watching💤 Quiet
Interest: 33/100
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced or Metastatic Solid Tumors
Conditions
Advanced or Metastatic Solid Tumors
Trial Timeline
Apr 19, 2017 → Mar 1, 2027
NCT ID
NCT03155061About ONO-4578 + ONO-4538
ONO-4578 + ONO-4538 is a phase 1 stage product being developed by Ono Pharmaceutical for Advanced or Metastatic Solid Tumors. The current trial status is active. This product is registered under clinical trial identifier NCT03155061. Target conditions include Advanced or Metastatic Solid Tumors.
What happened to similar drugs?
16 of 20 similar drugs in Advanced or Metastatic Solid Tumors were approved
Approved (16) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
6
Activity
12
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03155061 | Phase 1 | Active |
Competing Products
20 competing products in Advanced or Metastatic Solid Tumors